Tighe M R, Hall M A, Ashkenazi A, Siegler E, Lanchbury J S, Ciclitira P J
Rayne Institute, St. Thomas' Hospital, London, England.
Hum Immunol. 1993 Dec;38(4):270-6. doi: 10.1016/0198-8859(93)90554-e.
The immunogenetics of celiac disease demonstrates a highly significant association with the HLA class II alleles DQA10501 DQB10201 encoded in either a cis- or trans-configuration. In Northern Europe, these alleles are found in linkage disequilibrium with DRB10301 while in Southern Europe an additional secondary association through linkage disequilibrium is seen with the combination DRB11101/0701. This study examines 34 Ashkenazi Jews with celiac disease and 36 ethnically matched controls to determine alleles at the DRB, DQA1, DQB1, and DPB1 loci using SSO probes in conjunction with gene amplification by the PCR. The results confirm a highly significant association with the DQA10501 DQB10201 allelic combination (71% celiac vs 8% control individuals; p = 0.00005; chi 2 = 21.4). Of celiac subjects, 29% were negative for the proposed DQ susceptibility alleles, the majority of whom were DRB10402 positive (20% overall celiac group). No additional susceptibility was associated at the DRB3 and DPB loci. This study confirms that the MHC-linked celiac disease susceptibility among Ashkenazi Jews is closely associated with the presence of the combination of alleles DQA10501 DQB1*0201. However, within this population of relatively high-prevalence celiac disease, 30% of celiac patients do not carry these alleles and are therefore not covered by a single "unifying" hypothesis.
乳糜泻的免疫遗传学显示,与以顺式或反式构型编码的HLA II类等位基因DQA10501 DQB10201存在高度显著关联。在北欧,这些等位基因与DRB10301处于连锁不平衡状态,而在南欧,通过连锁不平衡还可观察到与DRB11101/0701组合存在额外的次要关联。本研究检测了34名患有乳糜泻的阿什肯纳兹犹太人以及36名种族匹配的对照者,使用序列特异性寡核苷酸(SSO)探针结合聚合酶链反应(PCR)进行基因扩增,以确定DRB、DQA1、DQB1和DPB1基因座的等位基因。结果证实与DQA10501 DQB10201等位基因组合存在高度显著关联(乳糜泻患者中71%,对照个体中8%;p = 0.00005;卡方 = 21.4)。在乳糜泻患者中,29%对提议的DQ易感等位基因为阴性,其中大多数为DRB10402阳性(占整个乳糜泻组的20%)。在DRB3和DPB基因座未发现额外的易感性。本研究证实,阿什肯纳兹犹太人中与MHC相关的乳糜泻易感性与等位基因DQA10501 DQB1*0201的组合密切相关。然而,在这个乳糜泻患病率相对较高的人群中,30%的乳糜泻患者不携带这些等位基因,因此不受单一“统一”假说的涵盖。